Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in Daily Practice

Novo Nordisk

Status: Completed

Conditions: Diabetes; Diabetes Mellitus, Type 2

Treatments: Drug: liraglutide

Study type: Observational

Funder types: Industry

Identifiers

NCT02255266

U1111-1143-9842 (Other Identifier)

NN2211-4118

Details and patient eligibility

About

This study is conducted in Europe. The aim of this study is to investigate Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in daily Practice.

Enrollment: 1,788 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subjects of age above 18 years as per Victoza® SmPC par.4.2 and 5.1 diagnosed with type 2 diabetes receiving the first prescription of liraglutide in 2011

Exclusion criteria

• None. Available data from all eligible patients for each center, will be included

Trial design

1,788 participants in 1 patient group

A

Treatment:

Drug: liraglutide